Physician profile
Adam J Keefer
NPI 1396855060
$31,644.23
in general payments reported to CMS, 2019-2025
30 companies · $1,384 in 2025
The $1,384 reported for 2025 was more than what a typical Vascular Surgery provider received nationally (typical 2025 total: $927).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,002 · 2020: $2,345 · 2021: $603 · 2022: $21K · 2023: $3,484 · 2024: $1,118 · 2025: $1,384.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,822 · Consulting Fee: $1,100 · Travel and Lodging: $1,065.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,821.96 |
| Consulting Fee | $1,100.00 |
| Travel and Lodging | $1,064.93 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Endologix LLC | $23,597.74 | 2021-2025 | Endocross Device, Torus Stent Graft System, Afx2 Bifurcated Endograft System |
| Medtronic Vascular, INC. | $3,255.08 | 2019-2020 | |
| Medtronic, INC. | $1,586.67 | 2021-2025 | Abre, Turbohawk, Venaseal |
| Philips North America LLC | $718.77 | 2023-2025 | IV Other, Labosys, Pioneer |
| W. L. Gore & Associates, INC. | $429.01 | 2019-2024 | Gore Viabahn Endoprosthesis, Gore Excluder Iliac Branch Endoprosthesis |
| Boston Scientific Corporation | $304.07 | 2020-2025 | Varithena Administration Pack |
| Cook Medical LLC | $243.96 | 2019-2022 | |
| Biocompatibles, INC. | $212.94 | 2019 | |
| Merz North America, INC. | $141.13 | 2020-2021 | |
| Silk Road Medical, INC. | $137.38 | 2019-2024 | Enroute Transcarotid Neuroprotection System, Enroute Enflate Transcarotid Rx Balloon Dilatation Catheter, Enroute Transcarotid Stent |
| Access Pro Medical, LLC | $126.42 | 2023 | Matriderm |
| Kci USA, INC. | $123.28 | 2022 | |
| Bolton Medical INC | $94.57 | 2022 | |
| Lemaitre Vascular, INC. | $82.10 | 2022-2025 | Artegraft Vascular Graft |
| Smith+Nephew, INC. | $72.25 | 2022-2025 | Renasys Touch, Renasys Go V2 Home, Stravix |
Show all 30 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $69.46 | 2019-2022 | |
| Organogenesis INC. | $68.28 | 2022-2024 | Puraply Am |
| Bioventus LLC | $64.40 | 2022-2023 | |
| Convatec INC. | $50.06 | 2023 | |
| Janssen Pharmaceuticals, INC | $44.47 | 2019-2020 | |
| Becton, Dickinson and Company | $38.49 | 2025 | Rotarexs 6 F X 135 Cm |
| Bard Peripheral Vascular, INC. | $34.17 | 2025 | Lutonix Drug Coated Balloon |
| Pfizer INC. | $31.65 | 2023 | |
| Ethicon US, LLC | $23.64 | 2024 | Stratafix, Dermabond Prineo, Surgicel Nu-Knit |
| Biowound Solutions, INC. | $19.77 | 2025 | Bio-Connekt |
| Abbvie INC. | $17.33 | 2023 | |
| Cordis US Corp. | $16.86 | 2025 | Saber |
| Cashflow Solutions, LLC | $14.15 | 2025 | Lympha Press Optimal Plus(US) Bt, Pcd-51 731a (US) - White, Pcd-52 737a (US) White |
| Inari Medical, INC. | $13.13 | 2022 | |
| Cardiva Medical, INC. | $13.00 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Adam Keefer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.